These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6226279

  • 1. Cyproterone acetate and the treatment of hirsutism.
    Fraser IS, Shearman RP, Allen JK, McCarron G.
    Aust N Z J Obstet Gynaecol; 1983 May; 23(2):93-8. PubMed ID: 6226279
    [Abstract] [Full Text] [Related]

  • 2. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M, Lachinsky N, Moolenaar AJ.
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [Abstract] [Full Text] [Related]

  • 3. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A, Gallardo E.
    Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
    [Abstract] [Full Text] [Related]

  • 4. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L, Galbignani E.
    Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
    [Abstract] [Full Text] [Related]

  • 5. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA, Demers LM, Applebaum-Bowden D, Lenker R.
    Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
    [Abstract] [Full Text] [Related]

  • 6. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
    Barth JH, Cherry CA, Wojnarowska F, Dawber RP.
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
    [Abstract] [Full Text] [Related]

  • 7. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
    Garner PR, Poznanski N.
    J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
    [Abstract] [Full Text] [Related]

  • 8. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M, Yücelten D, Gürbüz O, Durmuşoğlu F, Pekin S.
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [Abstract] [Full Text] [Related]

  • 9. New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women.
    Hirvonen E, Stenman UH, Mälkönen M, Rasi V, Vartiainen E, Ylöstalo P.
    Maturitas; 1988 Oct; 10(3):201-13. PubMed ID: 2972897
    [Abstract] [Full Text] [Related]

  • 10. [Anti-androgen treatment of hirsutism with cyproterone acetate].
    Kása M, Egyedi K, Raffai S, Török L.
    Z Hautkr; 1990 Dec; 65(12):1112-4. PubMed ID: 2150902
    [Abstract] [Full Text] [Related]

  • 11. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L, Pasinetti E.
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [Abstract] [Full Text] [Related]

  • 12. The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism.
    Seed M, Godsland IF, Wynn V, Jacobs HS.
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):689-99. PubMed ID: 6239714
    [Abstract] [Full Text] [Related]

  • 13. Cyproterone acetate for hirsutism.
    Van der Spuy ZM, le Roux PA.
    Cochrane Database Syst Rev; 2003 Dec; 2003(4):CD001125. PubMed ID: 14583927
    [Abstract] [Full Text] [Related]

  • 14. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R.
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [Abstract] [Full Text] [Related]

  • 15. Effects of the cyproterone acetate + ethynil oestradiol antiandrogen association on blood coagulation and fibrinolysis in hirsute women.
    Ghezzo F, Manieri C, Rodi R, Messina M, Molinatti GM.
    Panminerva Med; 1981 Mar; 23(4):223-6. PubMed ID: 6212899
    [No Abstract] [Full Text] [Related]

  • 16. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Evaluation of the clinical effect].
    Pedersen IM, Nielsen DR, Larsen J, Starup J.
    Ugeskr Laeger; 1985 Aug 12; 147(33):2594-6. PubMed ID: 2933858
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms.
    Acién P, Mauri M, Gutierrez M.
    Hum Reprod; 1997 Mar 12; 12(3):423-9. PubMed ID: 9130733
    [Abstract] [Full Text] [Related]

  • 18. Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women.
    Vermeulen A, Rubens R.
    Contraception; 1988 Oct 12; 38(4):419-28. PubMed ID: 2974791
    [Abstract] [Full Text] [Related]

  • 19. The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women.
    Frölich M, Vader HL, Walma ST, De Rooy HA.
    J Steroid Biochem; 1980 Jan 12; 12():499-501. PubMed ID: 6448324
    [No Abstract] [Full Text] [Related]

  • 20. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
    Mastorakos G, Koliopoulos C, Creatsas G.
    Fertil Steril; 2002 May 12; 77(5):919-27. PubMed ID: 12009344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.